Validus Holdings, Ltd. (NYSE:VR) had its price target decreased by UBS AG from $50.00 to $48.00 in a research note issued to investors on Monday morning, www.benzinga.com reports. UBS AG currently has a neutral rating on the insurance provider’s stock.

Several other equities analysts have also recently issued reports on VR. BidaskClub raised Validus Holdings from a strong sell rating to a sell rating in a research report on Wednesday, June 14th. Zacks Investment Research cut Validus Holdings from a buy rating to a hold rating in a research report on Friday, July 7th. Keefe, Bruyette & Woods set a $55.00 price objective on Validus Holdings and gave the company a hold rating in a research report on Thursday, August 17th. ValuEngine raised Validus Holdings from a hold rating to a buy rating in a research report on Friday, September 1st. Finally, Buckingham Research started coverage on Validus Holdings in a research report on Monday, September 11th. They issued a buy rating and a $52.00 price objective on the stock. Two analysts have rated the stock with a sell rating, four have issued a hold rating and three have issued a buy rating to the stock. The stock has an average rating of Hold and an average price target of $55.50.

Shares of Validus Holdings (NYSE:VR) opened at 48.93 on Monday. The company’s 50-day moving average price is $48.79 and its 200-day moving average price is $52.53. Validus Holdings has a one year low of $41.15 and a one year high of $58.76. The company has a market capitalization of $3.89 billion, a price-to-earnings ratio of 13.49 and a beta of 0.65.

Validus Holdings (NYSE:VR) last posted its quarterly earnings results on Thursday, July 27th. The insurance provider reported $1.09 earnings per share for the quarter, topping the consensus estimate of $0.99 by $0.10. The company had revenue of $675.27 million for the quarter, compared to the consensus estimate of $922.84 million. Validus Holdings had a return on equity of 7.75% and a net margin of 11.81%. During the same quarter in the prior year, the business posted $0.66 EPS. On average, equities research analysts predict that Validus Holdings will post $2.77 earnings per share for the current year.

COPYRIGHT VIOLATION WARNING: This piece was first published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this piece on another site, it was copied illegally and reposted in violation of international copyright law. The correct version of this piece can be viewed at https://www.thecerbatgem.com/2017/10/05/validus-holdings-ltd-vr-pt-lowered-to-48-00-at-ubs-ag.html.

The company also recently declared a quarterly dividend, which was paid on Friday, September 29th. Stockholders of record on Friday, September 15th were issued a dividend of $0.38 per share. The ex-dividend date was Thursday, September 14th. This represents a $1.52 annualized dividend and a dividend yield of 3.11%. Validus Holdings’s payout ratio is 41.87%.

A number of institutional investors have recently made changes to their positions in the stock. Lord Abbett & CO. LLC raised its holdings in Validus Holdings by 1.7% in the 2nd quarter. Lord Abbett & CO. LLC now owns 1,575,434 shares of the insurance provider’s stock worth $81,875,000 after purchasing an additional 25,828 shares during the period. Laurel Wealth Advisors Inc. raised its holdings in Validus Holdings by 11.1% in the 2nd quarter. Laurel Wealth Advisors Inc. now owns 9,230 shares of the insurance provider’s stock worth $479,000 after purchasing an additional 920 shares during the period. Tower Research Capital LLC TRC raised its holdings in Validus Holdings by 1,257.2% in the 2nd quarter. Tower Research Capital LLC TRC now owns 3,678 shares of the insurance provider’s stock worth $191,000 after purchasing an additional 3,407 shares during the period. The Manufacturers Life Insurance Company raised its holdings in Validus Holdings by 10.1% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 2,382 shares of the insurance provider’s stock worth $124,000 after purchasing an additional 219 shares during the period. Finally, Caxton Associates LP bought a new position in Validus Holdings in the 2nd quarter worth $667,000. 93.51% of the stock is currently owned by institutional investors.

About Validus Holdings

Validus Holdings, Ltd. is a holding company. The Company operates through four segments: Validus Re, Talbot, Western World and AlphaCat. Validus Re is a Bermuda-based reinsurance segment focused treaty reinsurance. Validus Re concentrates on first-party property and other reinsurance risks. Talbot is a specialty insurance segment operating within the Lloyd’s insurance market through Syndicate 1183.

Analyst Recommendations for Validus Holdings (NYSE:VR)

Receive News & Stock Ratings for Validus Holdings Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Validus Holdings Ltd. and related stocks with our FREE daily email newsletter.